BOHEMIA is a consortium led by ISGlobal and funded by Unitaid. It includes two African institutions: the Centro de Investigação em Saúde de Manhiça (CISM) in Mozambique, and the Ifakara Health Institute (IFI) in Tanzania, and three academic partners: the University Hospital Bern, the University of Oxford, and Virginia Tech.
The Barcelona Institute for Global Health, ISGlobal, is a cutting-edge institute with the capacity to address global public health challenges through research, knowledge translation and education. It has a broad research portfolio in communicable and non-communicable diseases and environmental factors. ISGlobal is known for its long history and achievements in the field of malaria, and is a WHO Collaborating Center for Malaria Control, Elimination and Eradication.
Centro de Investigação em Saúde de Manhiça (CISM)
The Manhiça Health Research Centre (CISM), in Mozambique, was created in 1996 as a collaborative program between the Spanish Agency for International Cooperation for Development (AECID), the Ministry of Health in Mozambique, the Fundació Clínic per a la Recerca Biomèdica (FCRB) and the National Health Institute to promote and conduct biomedical research in priority areas aimed at improving the health of the most vulnerable populations. For more than two decades, CISM, through its research activities, has sought to find solutions both in the area of malaria treatment, diagnosis and prevention. With a team of researchers of recognized national and international merit, the Centre positions itself at the highest levels of malaria research, covering clinical-epidemiological research and clinical trials of new drugs and vaccines, as well as monitoring of morbidity, mortality and transmission intensity of this disease. The CISM has the role of developing and coordinating activities in the field in Mozambique.
Ifakara Health Institute (IHI)
The Ifakara Health Institute (IHI), in Tanzania, is a leading research organization in Africa, with strong track records in developing, testing and validating innovations for health. The institute’s work spans across a wide spectrum of sciences including biomedical and ecological sciences, intervention studies, health-systems research, monitoring and evaluation and policy translation. IHI hosts the clinical trial in Tanzania – one of the two eco-epidemiological settings in east and southern Africa.
University Hospital Bern
The Inselspital, University Hospital Bern is the largest public hospital group in Switzerland and is associated with University of Bern. It holds a key position in research and teaching in the Swiss healthcare system, enjoys an excellent international reputation as an incubator for innovation and venue of the science community.
University of Oxford
The Centre for Tropical Medicine and Global Health is a world leading Centre within the Nuffield Department of Clinical Medicine, University of Oxford, comprised of research groups who are permanently based in Africa and Asia as well as across two sites in Oxford. It’s research ranges from clinical studies to behavioural sciences, with capacity building integral to all of our activities. Through their facilities in Kenya, they are engaged as a core laboratory and training for PCR, cross social sciences package, and leading entomology for BOHEMIA.
Virginia Tech fulfils its role as a land-grant university by fostering a collaborative environment that integrates technology into all disciplines. The university is home to the Virginia-Maryland College of Veterinary Medicine, a leading biomedical teaching and research centre focused on the development and delivery of a One Health education. The college conducts a broad spectrum of basic/molecular and translational/applied research which aims to better understand diseases that afflict both humans and animals, and to develop vaccines and
About our donor
Unitaid brings the power of new medical discoveries to the people who most need them and helps set the stage for large-scale introduction of new health products by collaborating with governments and partners such as PEPFAR, the Global Fund and WHO. Unitaid invests in new ways to prevent, diagnose and treat diseases including HIV/AIDS, hepatitis C, tuberculosis and malaria more quickly, affordably and effectively. A growing number of their programs address more than one disease, maximizing effectiveness of health systems.